Export to BibTeX Export to EndNoteEfficacy, Safety And Tolerability Of Atorvastatin In Patients With Relapsing-Remitting Multiple Sclerosis In Treatment With Interferon-Beta (arianna): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group-Study, Lyon. France (84 views)
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
Proceedings Of The 23rd Ectrims Meeting Lyon France, 2012 Oct 10; AbstractBook: 477-477.
Abstract
Not available.
Affiliations ▼
| *** IBB - CNR Affiliation |
Details ▼
Impact factor: 0, 5-year impact factor: 0
Paper type: Abstract, Conference,
Keywords: Not available.
Url: Not available. |
References ▼
Related activities ▼
Related papers ▼
Related bibliography ▼
<=2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 ALL YEARS
Sort by: date ▼▲ title ▲ ▼ journal ▲ ▼ authors ▲ ▼ impact factor ▲ ▼* Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study (72 views)Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2012 Oct; 18: 197-197.
View Export to BibTeX Export to EndNote Upload PDF
* Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial of combination therapy (37 views)Lanzillo R, Orefice G, Quarantelli M, Rinaldi C, Prinster A, Ventrella G, Spitaleri D, Lus G, Vacca G, Carotenuto B, Salvatore E, Brunetti A, Tedeschi G, Brescia Morra V
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Apr; 16(4): 450-454.
View Export to BibTeX Export to EndNote Upload PDF
2 Records ( 1 excluding Abstracts and Conferences). Total impact factor: 9.726 ( 4.863 excluding Abstracts and Conferences). Total 5-year impact factor: 8.552 ( 4.276 excluding Abstracts and Conferences).
Your bibliography query: (([btitle, keywords, abstract] EFFICACY AND [btitle, keywords, abstract] SAFETY AND [btitle, keywords, abstract] TOLERABILITY AND [btitle, keywords, abstract] ATORVASTATIN AND [btitle, keywords, abstract] PATIENTS AND [btitle, keywords, abstract] WITH AND [btitle, keywords, abstract] RELAPSING)) AND NOT [id] = 52478
|
|
Last modified by Marco Comerci on Friday 26 June 2015, 10:04:39
84 views. Last viewed on Tuesday 11 July 2017, 23:14:10
|
INCIPIT
ISTAPCA
Euro-BioImaging
Instruct-IT
Fondazione Veronesi
Fondo Europeo Pesca
INMiND
PRIN
eHealthNet
Ponrec
MFAG Grant
